As of 1:53pm ET
| -0.01 / -0.09%|
The 4 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +86.05% increase from the last price of 10.75.
The current consensus among 4 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.